Cognitive symptoms of Alzheimer’s disease: clinical management and prevention
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cognitive symptoms of Alzheimer’s disease: clinical management and prevention
Authors
Keywords
-
Journal
BMJ-British Medical Journal
Volume -, Issue -, Pages l6217
Publisher
BMJ
Online
2019-12-07
DOI
10.1136/bmj.l6217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular dysfunction—The disregarded partner of Alzheimer's disease
- (2019) Melanie D. Sweeney et al. Alzheimers & Dementia
- Amyloid-β Immunotherapy for Alzheimer's Disease - Is It Now A Long Shot…?
- (2019) Francesco Panza et al. ANNALS OF NEUROLOGY
- Exploring the relationship between physical activity, beta-amyloid and tau: A narrative review
- (2019) Belinda M. Brown et al. AGEING RESEARCH REVIEWS
- A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment
- (2019) Mélanie Fortier et al. Alzheimers & Dementia
- Alzheimer disease and aducanumab: adjusting our approach
- (2019) Dennis J. Selkoe Nature Reviews Neurology
- A brief history of “Alzheimer disease”
- (2019) David S. Knopman et al. NEUROLOGY
- A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia
- (2018) Ruth Knight et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Normalization and the Cholinergic Microcircuit: A Unified Basis for Attention
- (2018) Taylor W. Schmitz et al. TRENDS IN COGNITIVE SCIENCES
- Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial
- (2018) Sarah E Lamb et al. BMJ-British Medical Journal
- Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial
- (2018) Sarah E Lamb et al. BMJ-British Medical Journal
- Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2018) Ying-Chih Cheng et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Effects of Physical Activity in Nursing Home Residents with Dementia: A Randomized Controlled Trial
- (2018) Marinda Henskens et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial
- (2018) Philip Scheltens et al. JOURNAL OF ALZHEIMERS DISEASE
- A Nutritional Approach to Ameliorate Altered Phospholipid Metabolism in Alzheimer's Disease
- (2018) Tobias Hartmann et al. JOURNAL OF ALZHEIMERS DISEASE
- The role of brain vasculature in neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. NATURE NEUROSCIENCE
- Repetitive transcranial magnetic stimulation for the treatment of Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
- (2018) Xin Dong et al. PLoS One
- The effect of physical exercise on cerebral blood flow in Alzheimer's disease
- (2018) Lisa A. van der Kleij et al. NeuroImage-Clinical
- Effects of Exercise on Cognitive Function in Older People with Dementia: A Randomized Controlled Trial
- (2017) Annika Toots et al. JOURNAL OF ALZHEIMERS DISEASE
- Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment
- (2017) Sophie Sokolow et al. JOURNAL OF ALZHEIMERS DISEASE
- Adverse Events With Sustained-Release Donepezil in Alzheimer Disease
- (2017) Chunsoo Lee et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP
- (2017) Saket M. Nigam et al. JOURNAL OF NEUROCHEMISTRY
- 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
- (2017) Hilkka Soininen et al. LANCET NEUROLOGY
- Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis
- (2017) Ruey Chen et al. PLoS One
- Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial
- (2017) Jill K. Morris et al. PLoS One
- Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease
- (2016) Stephen C. Cunnane et al. Annals of the New York Academy of Sciences
- The Prevalence and Incidence of Dementia Due to Alzheimer’s Disease: a Systematic Review and Meta-Analysis
- (2016) Kirsten M. Fiest et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease
- (2016) Camilla Steen Jensen et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer’s disease
- (2016) A Coin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)
- (2016) Martin Knapp et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis
- (2016) Qing-Fei Zhao et al. JOURNAL OF AFFECTIVE DISORDERS
- A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease
- (2016) Andres M. Lozano et al. JOURNAL OF ALZHEIMERS DISEASE
- Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer’s Disease: A Randomized, Double-Blind Trial
- (2016) Akira Homma et al. JOURNAL OF ALZHEIMERS DISEASE
- Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?
- (2016) Matthew G. Bursavich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effects of Exercise on Cognition: The Finnish Alzheimer Disease Exercise Trial: A Randomized, Controlled Trial
- (2016) Hannareeta Öhman et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials
- (2016) Kelvin K.F. Tsoi et al. Journal of the American Medical Directors Association
- Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials
- (2016) Kelvin K.F. Tsoi et al. Journal of the American Medical Directors Association
- A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease
- (2016) Nathan Herrmann et al. Journal of the American Medical Directors Association
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews
- (2016) Kate Laver et al. BMJ Open
- EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease
- (2015) R. Schmidt et al. EUROPEAN JOURNAL OF NEUROLOGY
- Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials
- (2015) Taro Kishi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cholinesterase Inhibitor Discontinuation in Patients With Alzheimer’s Disease
- (2015) Jordana O’Regan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Physical Activity and Amyloid-βBrain Levels in Elderly Adults with Intact Cognition and Mild Cognitive Impairment
- (2015) Philipe de Souto Barreto et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
- (2015) Robert Howard et al. LANCET NEUROLOGY
- Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer's disease: a systematic review and meta-analysis
- (2015) Wan-Yu Hsu et al. NEUROBIOLOGY OF AGING
- The prediction of response to Galantamine treatment in Patients with mild to moderate Alzheimer’s Disease
- (2014) Takashi Ohnishi et al. Current Alzheimer Research
- Effect of Rivastigmine or Memantine Add-on Therapy Is Affected by Butyrylcholinesterase Genotype in Patients with Probable Alzheimer's Disease
- (2014) Hyun Jeong Han et al. EUROPEAN NEUROLOGY
- Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease
- (2014) Maurice W. Dysken et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of galantamine treatment for patients with Alzheimer’s disease: a meta-analysis of randomized controlled trials
- (2014) Deqi Jiang et al. JOURNAL OF NEURAL TRANSMISSION
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of exercise interventions on cognitive outcome in Alzheimer's disease: a systematic review
- (2013) Nicolas Farina et al. INTERNATIONAL PSYCHOGERIATRICS
- Concentration of Donepezil to the Cognitive Response in Alzheimer Disease
- (2013) Yuan-Han Yang et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effect of CYP2D6*10 and APOE Polymorphisms on the Efficacy of Donepezil in Patients With Alzheimer’s Disease
- (2012) Yuan Zhong et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimers Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine
- (2012) Rachelle S. Doody et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two galantamine titration regimens in patients switched from donepezil
- (2011) K. Engedal et al. ACTA NEUROLOGICA SCANDINAVICA
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative
- (2011) Lon S. Schneider ARCHIVES OF NEUROLOGY
- Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
- (2011) Martin Farlow et al. BMC Neurology
- Effects of Galantamine in Alzheimers Disease: Double-blind Withdrawal Studies Evaluating Sustained Versus Interrupted Treatment
- (2011) M. Gaudig et al. Current Alzheimer Research
- Medical Foods for Alzheimerʼs Disease
- (2011) Raj C. Shah DRUGS & AGING
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- What is the clinically relevant change on the ADAS-Cog?
- (2011) Anette Schrag et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis
- (2010) Delphine Boche et al. ACTA NEUROPATHOLOGICA
- Efficacy and Safety of Donepezil in Patients With Alzheimer’s Disease in Assisted Living Facilities
- (2010) Adam Rosenblatt et al. American Journal of Alzheimers Disease and Other Dementias
- Effects of Aerobic Exercise on Mild Cognitive Impairment
- (2010) Laura D. Baker et al. ARCHIVES OF NEUROLOGY
- Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
- (2010) Martin R. Farlow et al. CLINICAL THERAPEUTICS
- Neuropsychiatric Symptoms Underlying Caregiver Stress and Insight in Alzheimer’s Disease
- (2010) Paola Rocca et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- EFNS guidelines for the diagnosis and management of Alzheimer’s disease
- (2010) J. Hort et al. EUROPEAN JOURNAL OF NEUROLOGY
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease
- (2010) Joseph F. Quinn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials
- (2009) Bengt Winblad et al. CURRENT MEDICAL RESEARCH AND OPINION
- Physical Activity, Diet, and Risk of Alzheimer Disease
- (2009) Nikolaos Scarmeas JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial
- (2009) R. S. Doody et al. NEUROLOGY
- Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial
- (2009) Samuel T Henderson et al. Nutrition & Metabolism
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More